These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 23010565)

  • 1. Liquid crystalline phase nanodispersions enable skin delivery of siRNA.
    Vicentini FT; Depieri LV; Polizello AC; Del Ciampo JO; Spadaro AC; Fantini MC; Vitória Lopes Badra Bentley M
    Eur J Pharm Biopharm; 2013 Jan; 83(1):16-24. PubMed ID: 23010565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases.
    Petrilli R; Eloy JO; Praça FS; Del Ciampo JO; Fantini MA; Fonseca MJ; Bentley MV
    J Biomed Nanotechnol; 2016 May; 12(5):1063-75. PubMed ID: 27305826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in situ gelling liquid crystalline system based on monoglycerides and polyethylenimine for local delivery of siRNAs.
    Borgheti-Cardoso LN; Depieri LV; Kooijmans SA; Diniz H; Calzzani RA; Vicentini FT; van der Meel R; Fantini MC; Iyomasa MM; Schiffelers RM; Bentley MV
    Eur J Pharm Sci; 2015 Jul; 74():103-17. PubMed ID: 25917525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reverse hexagonal phase nanodispersion of monoolein and oleic acid for topical delivery of peptides: in vitro and in vivo skin penetration of cyclosporin A.
    Lopes LB; Ferreira DA; de Paula D; Garcia MT; Thomazini JA; Fantini MC; Bentley MV
    Pharm Res; 2006 Jun; 23(6):1332-42. PubMed ID: 16715364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase.
    Depieri LV; Borgheti-Cardoso LN; Campos PM; Otaguiri KK; Vicentini FT; Lopes LB; Fonseca MJ; Bentley MV
    Eur J Pharm Biopharm; 2016 Aug; 105():50-8. PubMed ID: 27224855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of protoporphyrin IX skin delivery for topical photodynamic therapy: Nanodispersions of liquid-crystalline phase as nanocarriers.
    Rossetti FC; Depieri LV; Praça FG; Del Ciampo JO; Fantini MC; Pierre MB; Tedesco AC; Bentley MV
    Eur J Pharm Sci; 2016 Feb; 83():99-108. PubMed ID: 26657201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of skin penetration of vitamin K using monoolein-based liquid crystalline systems.
    Lopes LB; Speretta FF; Bentley MV
    Eur J Pharm Sci; 2007 Nov; 32(3):209-15. PubMed ID: 17900879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self-assembling gelling formulation based on a crystalline-phase liquid as a non-viral vector for siRNA delivery.
    Borgheti-Cardoso LN; Depieri LV; Diniz H; Calzzani RA; de Abreu Fantini MC; Iyomasa MM; Moura de Carvalho Vicentini FT; Bentley MV
    Eur J Pharm Sci; 2014 Jul; 58():72-82. PubMed ID: 24726985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro TyRP-1 Knockdown Based on siRNA Carried by Liquid Crystalline Nanodispersions: an Alternative Approach for Topical Treatment of Vitiligo.
    Tofani LB; Depieri LV; Campos PM; Riul TB; Antonietto KS; de Abreu Fantini MC; Bentley MVLB
    Pharm Res; 2018 Mar; 35(5):104. PubMed ID: 29560584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery.
    Lopes LB; Lopes JL; Oliveira DC; Thomazini JA; Garcia MT; Fantini MC; Collett JH; Bentley MV
    Eur J Pharm Biopharm; 2006 Jun; 63(2):146-55. PubMed ID: 16621488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of internal structure and composition of liquid crystalline phases on topical delivery of paclitaxel.
    Hosmer JM; Shin SH; Nornoo A; Zheng H; Lopes LB
    J Pharm Sci; 2011 Apr; 100(4):1444-55. PubMed ID: 20957759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical delivery of siRNA into skin using SPACE-peptide carriers.
    Chen M; Zakrewsky M; Gupta V; Anselmo AC; Slee DH; Muraski JA; Mitragotri S
    J Control Release; 2014 Apr; 179():33-41. PubMed ID: 24434423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoolein liquid crystalline phases for topical delivery of crocetin.
    Esposito E; Carducci F; Mariani P; Huang N; Simelière F; Cortesi R; Romeo G; Puglia C
    Colloids Surf B Biointerfaces; 2018 Nov; 171():67-74. PubMed ID: 30015140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
    Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
    Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Situ Gelling Liquid Crystalline System as Local siRNA Delivery System.
    Borgheti-Cardoso LN; Kooijmans SAA; Fens MHAM; van der Meel R; Vicentini FTMC; Fantini MCA; Bentley MVLB; Schiffelers RM
    Mol Pharm; 2017 May; 14(5):1681-1690. PubMed ID: 28291360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lipid substitution on assembly and delivery of siRNA by cationic polymers.
    Aliabadi HM; Landry B; Bahadur RK; Neamnark A; Suwantong O; Uludağ H
    Macromol Biosci; 2011 May; 11(5):662-72. PubMed ID: 21322108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo pharmacokinetics, tissue distribution and underlying mechanisms of various PEI(-PEG)/siRNA complexes.
    Malek A; Merkel O; Fink L; Czubayko F; Kissel T; Aigner A
    Toxicol Appl Pharmacol; 2009 Apr; 236(1):97-108. PubMed ID: 19371615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted delivery of siRNA to activated T cells via transferrin-polyethylenimine (Tf-PEI) as a potential therapy of asthma.
    Xie Y; Kim NH; Nadithe V; Schalk D; Thakur A; Kılıç A; Lum LG; Bassett DJP; Merkel OM
    J Control Release; 2016 May; 229():120-129. PubMed ID: 27001893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyethylenimine/small interfering RNA-mediated knockdown of vascular endothelial growth factor in vivo exerts anti-tumor effects synergistically with Bevacizumab.
    Höbel S; Koburger I; John M; Czubayko F; Hadwiger P; Vornlocher HP; Aigner A
    J Gene Med; 2010 Mar; 12(3):287-300. PubMed ID: 20052738
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Liquid Crystal Formulation that Can Penetrate the Stratum Corneum for Intradermal Delivery of Small Interfering RNA.
    Kawai M; Ibaraki H; Takashima Y; Kanazawa T; Okada H
    Mol Pharm; 2021 Mar; 18(3):1038-1047. PubMed ID: 33395310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.